Hofheim, Germany

Burkhard Haase

This inventor holds 9 USPTO granted patents. Top assignees: Aventis Pharma Deutschland, Gmbh, Sanofi-A Ventis Deutschland Gmbh. Active years: 2000-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Burkhard Haase. Retrieved from https://idiyas.com/inventor/burkhard-haase

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 77.8

Average Co-Inventor Count = 4.2

ph-index = 5

Forward Citations = 85(Granted Patents)


Location History:

  • Maintal, DE (2001 - 2004)
  • Hofheim, DE (2000 - 2007)

Company Filing History:


Years Active: 2000-2007

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Mind of Burkhard Haase: A Look at His Contributions to Pharmaceuticals

Introduction: Burkhard Haase, a notable inventor based in Hofheim, Germany, has made significant contributions to the pharmaceutical industry through his inventive prowess. With a total of nine patents to his name, Haase has focused on developing compounds that address critical health issues, particularly those related to the activity of matrix-degrading metalloproteinases.

Latest Patents: Among Haase's notable inventions are his latest patents concerning sulfonylaminocarboxylic acids, which are compounds suitable for producing pharmaceuticals aimed at the prophylaxis and therapy of disorders involving increased matrix-degrading metalloproteinases activity. Additionally, he has developed cyclic and heterocyclic N-substituted α-iminohydroxamic and -carboxylic acids, showcasing his innovative approach to addressing complex medical challenges.

Career Highlights: Throughout his career, Burkhard Haase has been affiliated with prominent companies, including Aventis Pharma Deutschland GmbH and Aventis Pharma Deutschland GmbH. His work in these organizations has been instrumental in advancing pharmaceutical research and development.

Collaborations: He has collaborated with esteemed colleagues such as Werner Thorwart and Wilfried Schwab, combining their expertise to foster innovation and create groundbreaking pharmaceutical solutions.

Conclusion: Burkhard Haase's dedication to innovation in the pharmaceutical sector is evidenced by his impressive list of patents and collaborations. His contributions continue to play a vital role in developing therapies that address significant health concerns, solidifying his status as a prominent inventor in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…